According to Atara Biotherapeutics's latest financial reports the company's current revenue (TTM) is $34.7 M. In 2022 the company made a revenue of $63.57 M an increase over the years 2021 revenue that were of $20.34 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $8.57 M | -86.51% |
2022 | $63.57 M | 212.55% |
2021 | $20.34 M | |
2020 | N/A | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ImmunoGen
IMGN | $0.28 B | 728.76% | ๐บ๐ธ USA |
Agenus
AGEN | $0.16 B | 365.12% | ๐บ๐ธ USA |
Affimed
AFMD | $8.95 M | -74.19% | ๐ฉ๐ช Germany |